kynurenine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grégoire, L | 1 |
| Rassoulpour, A | 1 |
| Guidetti, P | 1 |
| Samadi, P | 1 |
| Bédard, PJ | 1 |
| Izzo, E | 1 |
| Schwarcz, R | 1 |
| Di Paolo, T | 1 |
1 other study available for kynurenine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskines | 2008 |